370 related articles for article (PubMed ID: 9865221)
1. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of assertive community treatment teams.
Essock SM; Frisman LK; Kontos NJ
Am J Orthopsychiatry; 1998 Apr; 68(2):179-90. PubMed ID: 9589757
[TBL] [Abstract][Full Text] [Related]
3. Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial.
Drake RE; McHugo GJ; Clark RE; Teague GB; Xie H; Miles K; Ackerson TH
Am J Orthopsychiatry; 1998 Apr; 68(2):201-15. PubMed ID: 9589759
[TBL] [Abstract][Full Text] [Related]
4. The REACT study: cost-effectiveness analysis of assertive community treatment in north London.
McCrone P; Killaspy H; Bebbington P; Johnson S; Nolan F; Pilling S; King M
Psychiatr Serv; 2009 Jul; 60(7):908-13. PubMed ID: 19564220
[TBL] [Abstract][Full Text] [Related]
5. [Study of the impact of an assertive community program on the families of patients with severe mental disorders].
Huguelet P; Koellner V; Boulguy S; Nagalingum K; Amani S; Borras L; Perroud N
Encephale; 2012 Jun; 38(3):201-10. PubMed ID: 22726408
[TBL] [Abstract][Full Text] [Related]
6. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
Jerrell JM; Ridgely MS
Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
[TBL] [Abstract][Full Text] [Related]
7. Evaluating use of continuous treatment teams for persons with mental illness and substance abuse.
Teague GB; Drake RE; Ackerson TH
Psychiatr Serv; 1995 Jul; 46(7):689-95. PubMed ID: 7552560
[TBL] [Abstract][Full Text] [Related]
8. Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS.
Rothbard AB; Metraux S; Blank MB
Psychiatr Serv; 2003 Sep; 54(9):1240-6. PubMed ID: 12954940
[TBL] [Abstract][Full Text] [Related]
9. Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study.
McHugo GJ; Drake RE; Teague GB; Xie H
Psychiatr Serv; 1999 Jun; 50(6):818-24. PubMed ID: 10375153
[TBL] [Abstract][Full Text] [Related]
10. Outcome for people with schizophrenia before and after Medicaid capitation at a community agency in Colorado.
Warner R; Huxley P
Psychiatr Serv; 1998 Jun; 49(6):802-7. PubMed ID: 9634161
[TBL] [Abstract][Full Text] [Related]
11. Criminal justice involvement, behavioral health service use, and costs of forensic assertive community treatment: a randomized trial.
Cusack KJ; Morrissey JP; Cuddeback GS; Prins A; Williams DM
Community Ment Health J; 2010 Aug; 46(4):356-63. PubMed ID: 20217230
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic limit setting in an assertive community treatment program.
Neale MS; Rosenheck RA
Psychiatr Serv; 2000 Apr; 51(4):499-505. PubMed ID: 10737826
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
[TBL] [Abstract][Full Text] [Related]
14. Substitution between Formal and Informal Care for Persons with Severe Mental Illness and Substance Use Disorders.
Clark RE; Xie H; Adachi-Mejia AM; Sengupta A
J Ment Health Policy Econ; 2001 Sep; 4(3):123-132. PubMed ID: 11967472
[TBL] [Abstract][Full Text] [Related]
15. An application of the thresholds of change model to the analysis of mental health data.
Xie H; McHugo G; Sengupta A; Hedeker D; Drake R
Ment Health Serv Res; 2001 Jun; 3(2):107-14. PubMed ID: 12109838
[TBL] [Abstract][Full Text] [Related]
16. Transition to low intensity case management in a VA Assertive Community Treatment model program.
Rosenheck RA; Neale MS; Mohamed S
Psychiatr Rehabil J; 2010; 33(4):288-96. PubMed ID: 20374987
[TBL] [Abstract][Full Text] [Related]
17. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
18. Three year outcomes of an early intervention for psychosis service as compared with treatment as usual for first psychotic episodes in a standard community mental health team - final results.
Agius M; Shah S; Ramkisson R; Murphy S; Zaman R
Psychiatr Danub; 2007 Sep; 19(3):130-8. PubMed ID: 17914313
[TBL] [Abstract][Full Text] [Related]
19. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
Clark RE; Xie H; Brunette MF
J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
